4
Changes in Ownership
Pharvaris N.V. Filed Acc 0001193125-26-288838
Chief Medical Officer sold 29,700 shares at an average $34.30 ($1,018,832)
- Chief Medical Officer acquired 29,700 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Lu Peng · Chief Medical Officer
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-06-25 | Exercise or conversion : show line 1 in the form 10b5-1 | +15,000 | $2.59 | $38,850 | 80,631 | D |
| 2026-06-25 | Sale : show line 2 in the form 10b5-1 | −11,600 | $34.45 | $399,675 | 69,031 | D |
| 2026-06-25 | Sale : show line 3 in the form 10b5-1 | −3,400 | $35.09 | $119,310 | 65,631 | D |
| 2026-06-26 | Exercise or conversion : show line 4 in the form 10b5-1 | +14,700 | $2.59 | $38,073 | 80,331 | D |
| 2026-06-26 | Sale : show line 5 in the form 10b5-1 | −14,700 | $34.00 | $499,847 | 65,631 | D |
| Open-market sales · 29,700 sh · avg $34.30 · $1,018,832 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-06-25 | Exercise or conversion : show line 6 in the form 10b5-1 Stock Option (Right to Buy) | −15,000 | 190,008 | D |
| 2026-06-26 | Exercise or conversion : show line 7 in the form 10b5-1 Stock Option (Right to Buy) | −14,700 | 175,308 | D |
Loading xslF345X06/ownership.xml…